- Home
- ADXN vs SSKN Comparison
ADXN vs SSKN Comparison
Compare ADXN & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- SSKN
- Stock Information
- Founded
- ADXN 2002
- SSKN 1989
- Country
- ADXN Switzerland
- SSKN United States
- Employees
- ADXN N/A
- SSKN N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- SSKN Medical/Dental Instruments
- Sector
- ADXN Health Care
- SSKN Health Care
- Exchange
- ADXN Nasdaq
- SSKN Nasdaq
- Market Cap
- ADXN 10.1M
- SSKN 9.7M
- IPO Year
- ADXN N/A
- SSKN 2005
- Fundamental
- Price
- ADXN $8.83
- SSKN $2.45
- Analyst Decision
- ADXN Strong Buy
- SSKN Strong Buy
- Analyst Count
- ADXN 1
- SSKN 1
- Target Price
- ADXN $30.00
- SSKN $6.00
- AVG Volume (30 Days)
- ADXN 14.4K
- SSKN 17.1K
- Earning Date
- ADXN 08-11-2025
- SSKN 08-13-2025
- Dividend Yield
- ADXN N/A
- SSKN N/A
- EPS Growth
- ADXN N/A
- SSKN N/A
- EPS
- ADXN 0.10
- SSKN N/A
- Revenue
- ADXN $278,508.00
- SSKN $33,620,000.00
- Revenue This Year
- ADXN $86.57
- SSKN $3.31
- Revenue Next Year
- ADXN N/A
- SSKN $9.67
- P/E Ratio
- ADXN $0.78
- SSKN N/A
- Revenue Growth
- ADXN N/A
- SSKN 3.30
- 52 Week Low
- ADXN $6.51
- SSKN $2.10
- 52 Week High
- ADXN $13.27
- SSKN $3.80
- Technical
- Relative Strength Index (RSI)
- ADXN 49.41
- SSKN 50.75
- Support Level
- ADXN $8.78
- SSKN $2.30
- Resistance Level
- ADXN $9.89
- SSKN $2.66
- Average True Range (ATR)
- ADXN 0.67
- SSKN 0.21
- MACD
- ADXN -0.03
- SSKN 0.02
- Stochastic Oscillator
- ADXN 43.01
- SSKN 28.99
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.